TECTONIC THERAPEUTIC, INC. Stock Split Ratio
TECTONIC THERAPEUTIC, INC. (TECX) had Stock Split Ratio of 53.00% as of 2024-06-20, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2026-02-26
- 2024-06-20: Stockholders' Equity Note, Stock Split, Conversion Ratio 53.00%.
- 2018-06-01: Stockholders' Equity Note, Stock Split, Conversion Ratio 431.20%; Stockholders' Equity Note, Stock Split, Conversion Ratio as first filed 24.20%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio as first filed |
|---|---|---|
| 2024-06-20 | 53.00% 10-K · filed 2026-02-26 | |
| 2018-06-01 | 431.20% 10-K · filed 2019-03-25 | 24.20% 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |